SPOTLIGHT: FDA can't manage foreign drugmaker inspections

A new report from the Government Accountability Office has concluded that the FDA doesn't have the resources to properly inspect foreign companies that manufacture drugs or drug ingredients. At present, the FDA can only inspect 8 percent of the more than 3,000 foreign companies that ship such items to the U.S., the GAO told Congress this week. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.